West shifts focus to proprietary products
West Pharmaceutical is changing its gauge from contract manufacturing to proprietary products: it’s particular focus, delivery systems.
Archives for May 22, 2012
US Senate votes on FDA safety and innovation act
The US FDA will have more powers to inspect ‘risky’ overseas pharmaceutical plants according to supporters of a bill being considered by the US senate this week.
Codexis strengthens relationship with Merck & Co
Industrial enzyme developer Codexis has had its supply contract extended by Merck & Co and been granted key patents for its Hep-C enzymes.
Recipharm says loan will fund takeovers and investment
Contract manufacturer Recipharm says a new loan will fund strategic acquisitions and investment in manufacturing facilities.
USP and FDA fattens-up QA standards for heparin
The US Pharmacopeial Convention (USP) and the FDA are calling for stricter quality standards for the production and supply of heparin.